NEW YORK--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq:URGN) a biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases because patients ...
April 24 (Reuters) - Tasly Pharmaceutical Group Co Ltd : * SAYS 2019 NET PROFIT DOWN 35.2% Y/Y AT 1.0 BILLION YUAN ($141.25 million) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback